Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's Next Round Of Drug Price Cuts? NDRC To Slash Prices On More Products On National Drug Reimbursement List

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's New Drug Price Guidelines are expected to be released by the end of this year, which are likely to lead to another round of price cuts on drugs included on the National Drug Reimbursement List, according to analysts
Advertisement

Related Content

China Sets New Rule For Drug Price Differentiation
Lost Patent Protection? Move To China, Says Specialty Biotech SciClone
China Likely To Delay Drug Price Cuts Until Next Year: Good News Or Bad?
Novartis' Myfortic Placed On China's National Drug Reimbursement List, Strengthens Portfolio On Immunosuppressant Therapy
Boehringer Ingelheim Opens R&D Center In Shanghai; Sees Sales Growth From Products On NDRL Reimbursement List
China's New Drug Price Policies Will Favor Big Distributors, Restrict Smaller Ones
China's New Guideline For Drug Pricing Favors Innovation And First-to-market Generics
China's New Guideline For Drug Pricing Favors Innovation And First-to-market Generics
China Boosts Health System Reforms With Expanded National Drug Reimbursement List
China Releases First Part Of Essential Drug List For Community Health Clinics And Rural Hospitals
Advertisement
UsernamePublicRestriction

Register

SC075792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel